metatools
SDTM supplemental-qualifier merging got sturdier, then the package went quiet for two years.
A side-by-side editorial comparison of marquee and pharmaversesdtm — release velocity, themes, recent moves, and the top alternatives to consider.
marquee is filling in the typographic details — outlines, border types, real font metrics for underlines.
marquee renders markdown text onto R graphics devices, and backs element_marquee() and geom_marquee() in ggplot2. Development ran in a tight burst through August and September 2025: 1.1.0 added text outlines, a size shortcut and remote PNG/JPEG support, 1.2.0 added border and outline line types and moved underline placement onto font metrics, and 1.2.1 cleaned up the bugs those introduced.
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
marquee renders markdown text onto R graphics devices, and backs element_marquee() and geom_marquee() in ggplot2. Development ran in a tight burst through August and September 2025: 1.1.0 added text outlines, a size shortcut and remote PNG/JPEG support, 1.2.0 added border and outline line types and moved underline placement onto font metrics, and 1.2.1 cleaned up the bugs those introduced.
The package is converging on typographic fidelity rather than new capability. Early work settled layout semantics — CSS margin collapsing, inline padding reserving space during shaping, devices without glyph support — and recent releases refine how decorations are drawn and measured. The naming cleanup in 1.2.0, border_size becoming border_width, reads as an API being tidied ahead of wider use rather than one still being explored.
Expect continued small releases sanding down rendering edge cases in ggplot2 contexts, since that is where the recent bug reports come from; nothing here signals a new feature area.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
Two kinds of work alternate: adding domains and biomarkers for a new indication, and making the existing data easier to reach — CSV copies under inst/extdata for non-R programmers, a datasets preview vignette, reference pages categorised by therapeutic area, variable-by-variable breakdowns. Consistency fixes against CDISC terminology and SDTM guidelines run through every release.
New therapeutic areas will keep arriving in step with the admiral extension packages that need them; the neurology and metabolic datasets landed just ahead of admiralneuro and admiralmetabolic needing them, and lymphoma looks like the next in that sequence.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either marquee or pharmaversesdtm.
SDTM supplemental-qualifier merging got sturdier, then the package went quiet for two years.
A clinical-script logger that stopped shipping after its 0.2 line, changelogs made of merged PRs.
R's object inspector is losing its view of the internals as CRAN closes off the private C API.
A weather-station data client that broke one return type to hand back distances instead of bare IDs.
giscoR's 1.0 moved its dataset index into the cache, so new Eurostat releases arrive without a package update.
FedData has spent two major versions migrating US federal geodata off R's retiring spatial stack.
See all marquee alternatives → · See all pharmaversesdtm alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. marquee and pharmaversesdtm are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. marquee and pharmaversesdtm are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top marquee alternatives in Analytics are ranked by recent ship velocity. Browse the "marquee alternatives" section above for the current picks, or visit /alternatives/marquee for the full list with editorial commentary on each.
Top pharmaversesdtm alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaversesdtm alternatives" section above for the current picks, or visit /alternatives/pharmaversesdtm for the full list with editorial commentary on each.